Literature DB >> 25600456

[MHC class I antigens, CD4 and CD8 expressions in polymyositis and dermatomyositis].

Carla Renata Graça1, João Aris Kouyoumdjian2.   

Abstract

OBJECTIVE: To analyze the frequencies of the expression of major histocompatibility complex class I (MHC-I) antigens, and CD4 and CD8 cells in skeletal muscle in polymyositis (PM) and dermatomyositis (DM).
METHODS: This was a retrospective study of 34 PM cases, 8 DM cases, and 29 control patients with non-inflammatory myopathies.
RESULTS: MHC-I antigens were expressed in the sarcolemma and/or sarcoplasm in 79.4% of PM cases, 62.5% of DM cases, and 27.6% of controls (CD4 expression was observed in 76.5%, 75%, and 13.8%, respectively). There was a high suspicion of PM/DM (mainly PM) in patients in whom MHC-I antigens and CD4 were co-expressed. In 14.3% of PM/DM cases, we observed MHC-I antigens expression alone, without inflammatory cells.
CONCLUSION: MCH-I antigens expression and CD4 positivity might add to strong diagnostic suspicion of PM/DM. No cellular infiltration was observed in 14.3% of such cases.
Copyright © 2014 Elsevier Editora Ltda. All rights reserved.

Entities:  

Keywords:  Antígenos de complexo principal de histocompatibilidade classe I (MHC‐I); Biópsia muscular; Imuno‐histoquímica muscular; Inflammatory myopathies; Major histocompatibility complex class I antigens (MHC‐I); Miopatias inflamatórias; Muscle biopsy; Muscle immunohistochemistry; Muscle pathology; Patologia muscular

Mesh:

Substances:

Year:  2014        PMID: 25600456     DOI: 10.1016/j.rbr.2014.10.005

Source DB:  PubMed          Journal:  Rev Bras Reumatol        ISSN: 0482-5004


  2 in total

Review 1.  The Role of T Lymphocytes in Skeletal Muscle Repair From Traumatic and Contraction-Induced Injury.

Authors:  Michael R Deyhle; Robert D Hyldahl
Journal:  Front Physiol       Date:  2018-06-20       Impact factor: 4.566

2.  The IRE1α Arm of UPR Regulates Muscle Cells Immune Characters by Restraining p38 MAPK Activation.

Authors:  RuiCai Gu; Tao Huang; JiangWei Xiao; ZhaoHong Liao; JunHua Li; HaiQiang Lan; Jun Ouyang; JiJie Hu; Hua Liao
Journal:  Front Physiol       Date:  2019-09-19       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.